Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

450960

Sigma-Aldrich

Lutetium(III) chloride

anhydrous, powder, 99.99% trace metals basis

Sinônimo(s):

Lutetium chloride, Lutetium trichloride

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula linear:
LuCl3
Número CAS:
10099-66-8
Peso molecular:
281.33
Número CE:
233-240-1
Número MDL:
MFCD00011099
Código UNSPSC:
12352302
ID de substância PubChem:
24868595
NACRES:
NA.23

grau

anhydrous

Ensaio

99.99% trace metals basis

Formulário

powder

adequação da reação

reagent type: catalyst
core: lutetium

Impurezas

≤150.0 ppm Trace Rare Earth Analysis

pf

905 °C (lit.)

densidade

3.98 g/mL at 25 °C (lit.)

cadeia de caracteres SMILES

Cl[Lu](Cl)Cl

InChI

1S/3ClH.Lu/h3*1H;/q;;;+3/p-3

chave InChI

AEDROEGYZIARPU-UHFFFAOYSA-K

Aplicação

Lutetium(III) chloride can be used:
  • As a precursor to synthesize chiral bridged lutetium catalyst for asymmetric hydroamination.
  • As a starting material to prepare doped lutetium oxide nanophosphors.
  • To fabricate scintillation detectors such as lutetium aluminum garnet (LuAG).

acessório

Nº do produto
Descrição
Preços

Código de classe de armazenamento

11 - Combustible Solids

Classe de risco de água (WGK)

WGK 2

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable

Equipamento de proteção individual

dust mask type N95 (US), Eyeshields, Gloves

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number
MKCB0960V
MKBV8849V
MKBR4789V
MKAA0295
MKBQ5281V

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Pesquise por COA

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Os clientes também visualizaram

Slide 1 of 6

1 of 6

Lutetium (III) oxide 99.99% trace metals basis

Sigma-Aldrich

203661

Lutetium (III) oxide

Ytterbium(III) chloride anhydrous, powder, 99.9%

Sigma-Aldrich

439614

Ytterbium(III) chloride

Holmium(III) chloride anhydrous, powder, 99.9% trace metals basis

Sigma-Aldrich

450901

Holmium(III) chloride

Yttrium(III) chloride AnhydroBeads™, −10 mesh, 99.99% trace metals basis

Sigma-Aldrich

450103

Yttrium(III) chloride

Lanthanum(III) bromide AnhydroBeads™, −10 mesh, ≥99.99% trace metals basis

Sigma-Aldrich

449822

Lanthanum(III) bromide

Lutetium (III) oxide 99.9% trace metals basis

Sigma-Aldrich

289191

Lutetium (III) oxide

Sanjay Kumar Saxena et al.
Cancer biotherapy & radiopharmaceuticals, 32(10), 364-370 (2017-12-22)
The primary objective of this investigation is the development of a strategy for the synthesis of polyhydroxamic acid (PHA)-grafted cellulose film, its characterization, and evaluation of its usefulness for the preparation of
Usha Pandey et al.
Cancer biotherapy & radiopharmaceuticals, 34(5), 306-315 (2019-06-13)
Background: Transarterial radioembolization (TARE) represents an effective targeted therapeutic option for hepatocellular carcinoma (HCC), a cancer with high mortality
Ana Santidrián et al.
Physical chemistry chemical physics : PCCP, 22(18), 10063-10075 (2020-04-28)
In the present work, the effect of doping on electronic properties in bulk purified and filled arc-discharge single-walled carbon nanotubes samples is studied for the first time by in situ Raman spectroelectrochemical method. A major challenge to turn the potential
Raffaella Rossin et al.
Molecular pharmaceutics, 11(9), 3090-3096 (2014-08-01)
Radioimmunotherapy (RIT) of solid tumors is hampered by low tumor-to-nontumor (T/NT) ratios of the radiolabeled monoclonal antibodies resulting in low tumor doses in patients. Pretargeting technologies can improve the effectiveness of RIT in cancer therapy by increasing this ratio. We
Sander M J van Duijnhoven et al.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 56(9), 1422-1428 (2015-07-15)
Radioimmunotherapy and nuclear imaging (immuno-PET/SPECT) of cancer with radiometal-labeled antibody fragments or peptides is hampered by low tumor-to-kidney ratios because of high renal radiometal retention. Therefore, we developed and evaluated a pretargeting strategy using click chemistry in vivo to reduce
Exibir todos os documentos relacionados

Artigos

The Rare Earth Crisis—The Supply/Demand Situation for 2010–2015

The rare earth elements impact nearly everyone in the world. All of the people living in advanced technological countries and almost all those living in third world countries utilize the rare earths in their everyday living—the car that one drives (gasoline is refined from oil using rare earth catalysts and catalytic converters reduce the polluting emissions from the automotive exhaust), watching the news on TV (the red and green colors in TV screens), the telephones and computers we use to communicate (the permanent magnets in speakers and disc drives), just to name a few examples.

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica